Cargando…
Treatment of alcohol dependence in patients with co-morbid major depressive disorder – predictors for the outcomes with memantine and escitalopram medication
BACKGROUND: Alcohol dependence comorbid with major depressive disorder poses a major challenge in the clinical setting. The results in the treatment with selective serotonin re-uptake inhibitors have been conflicting. Thus, we compared in alcohol-dependent patients with co-morbid major depressive di...
Autores principales: | Muhonen, Leea H, Lahti, Jari, Sinclair, David, Lönnqvist, Jouko, Alho, Hannu |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2569922/ https://www.ncbi.nlm.nih.gov/pubmed/18834506 http://dx.doi.org/10.1186/1747-597X-3-20 |
Ejemplares similares
-
Regional White Matter Integrity Predicts Treatment Response to Escitalopram and Memantine in Geriatric Depression: A Pilot Study
por: Krause-Sorio, Beatrix, et al.
Publicado: (2020) -
Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021) -
Daylight saving time transitions and hospital treatments due to accidents or manic episodes
por: Lahti, Tuuli A, et al.
Publicado: (2008) -
µ-Opioid Receptor Gene (OPRM1) Polymorphism A118G: Lack of Association in Finnish Populations with Alcohol Dependence or Alcohol Consumption
por: Rouvinen-Lagerström, Noora, et al.
Publicado: (2013) -
Comparative efficacy of escitalopram in the treatment of major depressive disorder
por: Ali, Mazen K, et al.
Publicado: (2011)